Article
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells
10 Jun 2021
Abstract excerpt
Abstract Recently, we involved the carbohydrate-binding protein Galectin-3 (Gal-3) as a druggable target for KRAS-mutant-addicted lung and pancreatic cancers. Here, using glioblastoma patient-derived stem cells (GSCs), we identify and characterize a subset of Gal-3high glioblastoma (GBM) tumors mainly within the mesenchymal subtype that are addicted to Gal-3-mediated macropinocytosis. Using both genetic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
